Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-23-033118
Filing Date
2023-04-27
Accepted
2023-04-27 12:58:59
Documents
62
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2022_bespoke.htm   iXBRL 10-K 875314
2 CERTIFICATION f10k2022ex31-1_bespoke.htm EX-31.1 10270
3 CERTIFICATION f10k2022ex32-1_bespoke.htm EX-32.1 3293
9 GRAPHIC image_001.jpg GRAPHIC 21711
10 GRAPHIC image_002.jpg GRAPHIC 5734
  Complete submission text file 0001213900-23-033118.txt   4898051

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bspk-20221231.xsd EX-101.SCH 59408
5 XBRL CALCULATION FILE bspk-20221231_cal.xml EX-101.CAL 33499
6 XBRL DEFINITION FILE bspk-20221231_def.xml EX-101.DEF 260100
7 XBRL LABEL FILE bspk-20221231_lab.xml EX-101.LAB 550020
8 XBRL PRESENTATION FILE bspk-20221231_pre.xml EX-101.PRE 274821
56 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022_bespoke_htm.xml XML 385394
Mailing Address 2590 WALNUT ST. DENVER CO 80205
Business Address 2590 WALNUT ST. DENVER CO 80205 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

EIN.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52759 | Film No.: 23854046
SIC: 2834 Pharmaceutical Preparations